Effect of exercise training on inflammation status among people with metabolic syndrome

Metabolic Syndrome and Related Disorders

Volumn 10, Issue 4, 2012, Pages 267-272

  Stensvold, Dorthe ^a   Slørdahl, Stig Arild ^a,b   Wisløff, Ulrik ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INSULIN; INTERLEUKIN 18; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AEROBIC EXERCISE; ARTICLE; BODY FAT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INTERMETHOD COMPARISON; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RESISTANCE TRAINING;

ADIPOSE TISSUE; ADULT; BODY COMPOSITION; C-REACTIVE PROTEIN; EXERCISE; EXERCISE THERAPY; FEMALE; HUMANS; INFLAMMATION; INSULIN; INTERLEUKIN-18; INTERLEUKIN-6; MALE; METABOLIC SYNDROME X; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864257357     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2011.0140     Document Type: Article

References (41)

1. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-2716. (Pubitemid 35403784)
2. Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies. J Am Coll Cardio 2007;49:403-414. (Pubitemid 46135879)
3. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645.
4. Troseid M, Seljeflot I, Arnesen H. The role of interleukin-18 in the metabolic syndrome. Cardiovasc Diabetol 2010;9:11.
5. Ahonen TM, Saltevo JT, Kautiainen HJ, et al. The association of adiponectin and low-grade inflammation with the course of metabolic syndrome. Nutr Metab Cardiovasc Dis 2010; (in press).
6. Grundy SM, Hansen B, Smith SC Jr, et al. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 2004;109:551-556. (Pubitemid 38168522)
7. Esposito K, Giugliano D. The metabolic syndrome and inflammation: Association or causation? Nutr Metab Cardiovasc Dis 2004;14:228-232. (Pubitemid 39611863)
8. Haffner SM. The metabolic syndrome: Inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 2006;97:3A-11A. (Pubitemid 43139714)
9. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-1695.
10. Mathur N, Pedersen BK. Exercise as a mean to control lowgrade systemic inflammation. Mediators Inflamm 2008;2008: 109502.
11. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: The link between insulin resistance, obesity and diabetes. Trends Immunol 2004;25:4-7. (Pubitemid 38032801)
12. Libby P. Inflammation in atherosclerosis. Nature 2002;420: 868-874. (Pubitemid 36019640)
13. Romeo J, Warnberg J, Pozo T, et al. Physical activity, immunity and infection. Proc Nutr Soc 2010;69:390-399.
14. Sattar N, Gaw A, Scherbakova O, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414-419. (Pubitemid 36935533)
15. Koh KK, Han SH, Quon MJ. Inflammatory markers and the metabolic syndrome: Insights from therapeutic interventions. J Am Coll Cardiol 2005;46:1978-1985. (Pubitemid 41713578)
16. Hung J, McQuillan BM, Chapman CM, et al. Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arterioscler Thromb Vasc Biol 2005;25:1268-1273. (Pubitemid 40776620)
17. Dinarello CA. Interleukin-18 and the pathogenesis of inflammatory diseases. Semin Nephrol 2007;27:98-114.
18. Stensvold D, Tjonna AE, Skaug EA, et al. Strength training versus aerobic interval training to modify risk factors of metabolic syndrome. J Appl Physio 2010;108:804-810.
19. Troseid M, Lappegard KT, Mollnes TE, et al. The effect of exercise on serum levels of interleukin-18 and components of the metabolic syndrome. Metab Syndr Relat Disord 2009;7: 579-584.
20. Pietrobelli A, Formica C, Wang Z, et al. Dual-energy X-ray absorptiometry body composition model: Review of physical concepts. Am J Physiol 1996;271:E941-E951.
21. Andersen LF, Solvoll K, Johansson LR, et al. Evaluation of a food frequency questionnaire with weighed records, fatty acids, and alpha-tocopherol in adipose tissue and serum. Am J Epidemiol 1999;150:75-87. (Pubitemid 29297272)
22. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Inves 2003;112:1821-1830. (Pubitemid 38063705)
23. Presta I, Andreozzi F, Succurro E, et al. IL-18 gene polymorphism and metabolic syndrome. Nutr Metab Cardiovasc Dis 2009;19:e5-e6.
24. Dinarello CA. Interleukin-18. Methods 1999;19:121-132. (Pubitemid 29497762)
25. Gracie JA, Robertson SE, McInnes IB. Interleukin-18. J Leukoc Biol 2003;73:213-224. (Pubitemid 36158296)
26. Tan HW, Liu X, Bi XP, et al. IL-18 overexpression promotes vascular inflammation and remodeling in a rat model of metabolic syndrome. Atherosclerosis 2010;208:350-357.
27. Xing SS, Bi XP, Tan HW, et al. Overexpression of interleukin-18 aggravates cardiac fibrosis and diastolic dysfunction in fructose-fed rats. Mol Med 2010;16:465-470.
28. Kadoglou NP, Perrea D, Iliadis F, et al. Exercise reduces resistin and inflammatory cytokines in patients with type 2 diabetes. Diabetes Care 2007;30:719-721. (Pubitemid 46354360)
29. Kohut ML, McCann DA, Russell DW, et al. Aerobic exercise, but not flexibility/resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of beta-blockers, BMI, and psychosocial factors in older adults. Brain Behav Immun 2006;20: 201-209.
30. Esposito K, Pontillo A, Di Palo C, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: A randomized trial. JAMA 2003;289:1799-1804. (Pubitemid 37430249)
31. Christiansen T, Paulsen SK, Bruun JM, et al. Exercise training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers in obese subjects: A 12-week randomized intervention study. Am J Physiol Endocrinol Metab 2010;298:E824-E831.
32. Balducci S, Zanuso S, Nicolucci A, et al. Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr Metab Cardiovasc Dis 2010;20:608-617.
33. Calle MC, Fernandez ML. Effects of resistance training on the inflammatory response. Nutr Res Pract 2010;4:259-269.
34. de Salles BF, Simao R, Fleck SJ, et al. Effects of resistance training on cytokines. Int J Sports Med 2010;31:441-450.
35. Bruunsgaard H, Bjerregaard E, Schroll M, et al. Muscle strength after resistance training is inversely correlated with baseline levels of soluble tumor necrosis factor receptors in the oldest old. J Am Geriatr Soc 2004;52:237-241. (Pubitemid 38233486)
36. Cheung K, Hume P, Maxwell L. Delayed onset muscle soreness: Treatment strategies and performance factors. Sports Med 2003;33:145-164. (Pubitemid 36315023)
37. Esposito K, Marfella R, Ciotola M, et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: A randomized trial. JAMA 2004;292:1440-1446. (Pubitemid 39258336)
38. Church TS, Earnest CP, Thompson AM, et al. Exercise without weight loss does not reduce C-reactive protein: The INFLAME study. Med Sci Sports Exerc 2010;42:708-716.
39. Bruun JM, Stallknecht B, Helge JW, et al. Interleukin-18 in plasma and adipose tissue: Effects of obesity, insulin resistance, and weight loss. Eur J Endocrinol 2007;157:465-471. (Pubitemid 350018450)
40. Brandt C, Pedersen BK. The role of exercise-induced myokines in muscle homeostasis and the defense against chronic diseases. J Biomed Biotechnol 2010;2010:520258.
41. Steensberg A. The role of IL-6 in exercise-induced immune changes and metabolism. Exerc Immunol Rev 2003;9:40-47.